Literature DB >> 7766410

In vitro viability and ultrastructural changes in bovine oocytes treated with a vitrification solution.

E J Fuku1, J Liu, B R Downey.   

Abstract

Abattoir-derived oocytes were exposed to a concentrated cryoprotectant solution (DAP213: 2 M DMSO, 1 M acetamide, 3 M propanediol, and 10% FCS in TCM199) for 1.5 or 5 min at the germinal vesicle (GV) stage or after maturation in vitro (IVM). Their viability was assessed by in vitro fertilization (IVF) and culture (IVC) to blastocysts. To investigate the effect of DAP213 on the ultrastructure, GV and IVM oocytes were processed for transmission electron microscopy (TEM) before (control) or after exposure to the cryoprotectant. DAP213 induced profound ultrastructural modifications to the microvilli and mitochondria, resulted in large vesicle formation, and, most significantly, caused the premature release of the cortical granules (CG). In IVM oocytes exposed to the cryoprotectant for 5 min, exocytosis of CG into the perivitelline space was common and the IVF rate was reduced (P < .05). After exposure for 5 min, GV oocytes displayed clusters of CG comparable to controls, but after IVM-IVF, polyspermy rate was increased (P < .05). Furthermore, treated GV oocytes showed a reduced rate of cleavage and blastocyst formation and an increased percentage of oocytes exhibiting alterations in organelles, whereas the viability and ultrastructure of IVM oocytes treated for 1.5 min was not different from controls. These observations demonstrate that 1) cortical granule kinetics is one of the key elements controlling fertilizability of bovine oocytes treated with cryoprotectant, and 2) GV oocytes are more sensitive to the cryoprotectant than those that have already been matured in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766410     DOI: 10.1002/mrd.1080400206

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

1.  Freeze/thaw stress induces organelle remodeling and membrane recycling in cryopreserved human mature oocytes.

Authors:  Stefania Annarita Nottola; Elena Albani; Giovanni Coticchio; Maria Grazia Palmerini; Caterina Lorenzo; Giulia Scaravelli; Andrea Borini; Paolo Emanuele Levi-Setti; Guido Macchiarelli
Journal:  J Assist Reprod Genet       Date:  2016-09-01       Impact factor: 3.412

Review 2.  Vitrification of human immature oocytes before and after in vitro maturation: a review.

Authors:  Mohammad Ali Khalili; Abbas Shahedi; Sareh Ashourzadeh; Stefania Annarita Nottola; Guido Macchiarelli; Maria Grazia Palmerini
Journal:  J Assist Reprod Genet       Date:  2017-08-18       Impact factor: 3.412

3.  The Nuclear Maturation and Embryo Development of Mice Germinal Vesicle Oocytes with and without Cumulus Cell after Vitrification.

Authors:  Mohsen Nikseresht; Mehdi Akbartabar Toori; Tahere Rasti; Iraj Ragerdi Kashani; Reza Mahmoudi
Journal:  J Clin Diagn Res       Date:  2015-01-01

4.  Euthanasia via CO2 inhalation causes premature cortical granule exocytosis in mouse oocytes and influences in vitro fertilization and embryo development.

Authors:  Liga Wuri; Cansu Agca; Yuksel Agca
Journal:  Mol Reprod Dev       Date:  2019-05-13       Impact factor: 2.609

5.  Vitrification of Rattus norvegicus immature cumulus-oocyte complexes using hyaluronic acid.

Authors:  L M G Paim; L L Gal; R F F Lopes; A T D Oliveira
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-22       Impact factor: 2.416

6.  Human oocyte vitrification: the permeability of metaphase II oocytes to water and ethylene glycol and the appliance toward vitrification.

Authors:  Steven F Mullen; Mei Li; Yuan Li; Zi-Jiang Chen; John K Critser
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

7.  Reversible disassembly of the actin cytoskeleton improves the survival rate and developmental competence of cryopreserved mouse oocytes.

Authors:  Basarab G Hosu; Steven F Mullen; John K Critser; Gabor Forgacs
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.